Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 3/20 | 0.58 |
| ▸ | PI4K2B | Q8TCG2 | 3/20 | 0.58 |
| ▸ | PI4K2A | Q9BTU6 | 3/20 | 0.58 |
| ▸ | PI4KB | Q9UBF8 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | XDH | P47989 | 1/20 | 0.58 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.43 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.43 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.43 |
| ▸ | GAPDH | P04406 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenine SCHEMBL38386 | 1.00 | PI4KA (0.58) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL7746165 | 1.00 | PI4KA (0.58) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL7624128 | 1.00 | PI4KA (0.58) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Dextrose SCHEMBL7886725 | 0.99 | PI4KA (0.56) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL8605925 | 0.84 | ADK (0.40) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL12542065 | 0.84 | HSD17B10 (0.40) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL1531264 | 0.84 | HSD17B10 (0.40) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL17824409 | 0.84 | ADK (0.40) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL7680729 | 0.84 | CYP3A4 (0.39) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL831005 | 0.84 | CYP3A4 (0.39) | PI4KAPI4K2BPI4K2API4KBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240024243-A1 | Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same | LABORATORY SKIN CARE, INC. | 2024-01-25 | — | — | US | claimed |
| CN-114236012-A | High performance liquid chromatography analysis method for coenzyme I content detection and application thereof | 上海蔚之星生物科技有限公司 | 2022-03-25 | — | — | CN | claimed |
| WO-2020230981-A2 | ATOPIC DERMATITIS ALLEVIATING AGENT COMPOSITION, ATOPIC DERMATITIS ALLEVIATING AGENT, AND PREPARATION METHOD THEREFOR | 오가닉브릿지 주식회사 | 2020-11-19 | — | — | WO | claimed |
| US-5397706-A | Serum-free basal and culture medium for hematopoietic and leukemia cells | CORREA PAULO N (CA) | 1995-03-14 | — | — | US | claimed |
| WO-1993009220-A1 | CELL CULTURE MEDIUM | CORREA PAULO N (CA) | 1993-05-13 | — | — | WO | claimed |
| JP-56142298-A | — | — | None | — | — | JP | disclosed |
| JP-56142297-A | — | — | None | — | — | JP | disclosed |
| JP-56142299-A | — | — | None | — | — | JP | disclosed |
| JP-56142296-A | — | — | None | — | — | JP | disclosed |
| JP-56142295-A | — | — | None | — | — | JP | disclosed |
| JP-56142294-A | — | — | None | — | — | JP | disclosed |
| US-12350352-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2025-07-08 | — | — | US | disclosed |
| EP-0354638-A2 | Use of adenosine and its derivatives in diagnosis | MEDCO RESEARCH INC (US) | 1990-02-14 | — | — | EP | disclosed |
| EP-0058563-A1 | Lyophilized phosphorylated nucleosides | ens BIO LOGICALS INC. (CA) | 1982-08-25 | — | — | EP | disclosed |
| JP-S56142295-A | ADENOSINE DERIVATIVE AND ITS PREPARATION | WAKUNAGA YAKUHIN KK | 1981-11-06 | — | — | JP | disclosed |
| JP-S56142294-A | ADENOSINE DERIVATIVE AND ITS PREPARATION | WAKUNAGA YAKUHIN KK | 1981-11-06 | — | — | JP | disclosed |
| JP-S56142296-A | ADENOSINE DERIVATIVE AND ITS PREPARATION | WAKUNAGA YAKUHIN KK | 1981-11-06 | — | — | JP | disclosed |
| JP-S56142298-A | OLIGONUCLEOTIDE DERIVATIVE AND ITS PREPARATION | WAKUNAGA YAKUHIN KK | 1981-11-06 | — | — | JP | disclosed |
| JP-S56142297-A | OLIGONUCLEOTIDE DERIVATIVE AND ITS PREPARATION | WAKUNAGA YAKUHIN KK | 1981-11-06 | — | — | JP | disclosed |
| JP-S56142299-A | PREPARATION OF OLIGONUCLEOTIDE | WAKUNAGA YAKUHIN KK | 1981-11-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12350352-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | PI4KA 2543/4885PI4K2B 2673/4885PI4K2A 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.